Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2016

01-11-2016 | Letter to the Editor

Clinical presentation of the hemoglobin Youngstown variant in a Chinese family

Authors: Yumei Huang, Man Wang, Chunlan Yu, Yu Lei, Yongrong Lai, Rongrong Liu

Published in: Annals of Hematology | Issue 11/2016

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Edward HL, Du Pisani LA, Rodriguez-Romero WE, Chaves-Villalobos J, Garcia-Quesada J, Harris NS, Luo HY, Steinberg MH, Forget BG, Chui DHK (2014) Hb Youngstown [beta 101(G3)Glu - > Ala; HBB: c.305A > C]: an unstable hemoglobin variant causing severe hemolytic anemia. Hemoglobin 38(6):381–384. doi:10.​3109/​03630269.​2014.​971960 CrossRefPubMed
2.
3.
4.
Butthep P, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S (2015) Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients. Blood Cell Mol Dis 54(2):170–176. doi:10.​1016/​j.​bcmd.​2014.​11.​007 CrossRef
5.
Origa R, Barella S, Argiolas GM, Bina P, Agus A, Galanello R (2008) No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia. Haematologica 93(7):1095–1096. doi:10.​3324/​haematol.​12484 CrossRefPubMed
6.
Taher AT, Musallam KM, Wood JC, Cappellini MD (2010) Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients. Am J Hematol 85(4):288–290. doi:10.​1002/​ajh.​21626 CrossRefPubMed
7.
Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, Liu Y, Amariglio N, Rechavi G, Rachmilewitz EA, Breuer W, Cabantchik ZI, Wrighting DM, Andrews NC, de Sousa M, Giardina PJ, Grady RW, Rivella S (2007) Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109(11):5027–5035. doi:10.​1182/​blood-2006-09-048868 CrossRefPubMedPubMedCentral
8.
9.
Metadata
Title
Clinical presentation of the hemoglobin Youngstown variant in a Chinese family
Authors
Yumei Huang
Man Wang
Chunlan Yu
Yu Lei
Yongrong Lai
Rongrong Liu
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2763-2

Other articles of this Issue 11/2016

Annals of Hematology 11/2016 Go to the issue

Letter to the Editor

Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants

Review Article

Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis

Erratum

Erratum to: Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major?

Letter to the Editor

Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis

Original Article

Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease

Original Article

Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits